ILMN
$ILMN
Illumina, Inc.
Leading genomic sequencing and DNA microarray technology company advancing precision medicine.
Healthcare$235.99
-54.07 (-18.64%)
Day Range$231.18 - $256.06
Prev Close$290.06
Analyst Rating
Buy
11 Buy / 7 Hold / 4 Sell
Price Target
$252.73
7.1% upside
Subscribers
0
Tracking this ticker
Latest Report
Analysis from Oct 31, 2026
ILMN: Post-Beat Reset, Mixed Signals Ahead
Illumina beat Q3 estimates and raised guidance, driven by clinical sequencing and NovaSeq X adoption, yet the stock fell sharply heading into the long weekend. This report outlines the financials, valuation, catalysts and trade-offs for retail investors.
Oct 31, 2026
Previous Reports
Keep exploring
- draft Illumina into a free practice contest: How to put the stock you just researched into a contest lineup at no real-money risk
- the healthcare sector brief for context on Illumina's peers: Today's sector-level news and moves around the stock